Interleukin 8 released after acute myocardial infarction is mainly bound to erythrocytes

Heart

Volumn 78, Issue 6, 1997, Pages 598-602

  De Winter, Robbert J ^a,c   Manten, Annemieke ^b   De Jong, Ype P ^b   Adams, Rob ^a   Van Deventer, Sander J H ^b   Lie, Kong I ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b A ^*

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Acute myocardial infarction; Interleukin 8

Indexed keywords

CREATINE KINASE MB; INTERLEUKIN 8;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; ERYTHROCYTE; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN SECRETION; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0031455161     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.78.6.598     Document Type: Article

References (35)

1. Entman ML, Michael L, Rossen RD, Dreyer WJ, Anderson DC, Taylor DC, et al. Inflammation in the course of early myocardial ischemia. FASEB J 1994;5:2529-37.
2. Brady AJB, Williams FM, Williams TJ. Inflammatory injury in myocardial ischaemia. Clin Sci 1994;83:511-18.
3. Tanaka M, Brooks SE, Richard VJ, FitzHarris GP, Stoler RC, Jennings RB, et al. Effect of anti-CD18 antibody on myocardial neutrophil accumulation and infarct size after ischemia and reperfusion in dogs. Circulation 1993;87:526-35.
4. Simpson PJ, Todd RF, Fantone JC, Mickelson JK, Griffin JD, Lucchesi BR. Reduction of experimental canine myocardial reperfusion injury by a monoclonal antibody (anti-Mo1, anti-CD11b) that inhibits leukocyte adhesion. J Clin Invest 1988;81:624-9.
5. Xin-Liang M, Lefer DJ, Lefer AM, Rothlein R. Coronary endothelial and cardiac protective effects of a monoclonal antibody to intercellular adhesion molecule-1 in myocardial ischemia and reperfusion. Circulation 1992;86:937-46.
6. Maury CPJ, Teppo AM. Circulating tumor necrosis factor-alpha (cachectin) in myocardial infarction. J Intern Med 1989;225:333-6.
7. Latini R, Bianchi M, Correale E, Dinarello CA, Fantuzzi G, Fresco C, et al. Cytokines in acute myocardial infarction: selective increase in circulating tumor necrosis factor, its soluble receptor, and interleukin-1 receptor antagonist. J Cardiovasc Pharmacol 1994;23:1-6.
8. Ikeda U, Ohkawa F, Seino Y, Yamamoto K, Hidaka Y, Kasahara T, et al. Serum interleukin-6 levels become elevated in acute myocardial infarction. J Mol Cell Cardiol 1992;24: 579-84.
9. Sturk A, Hack CE, Aarden LA, Brouwer M, Koster RW. Interleukin-6 release and the acute phase reaction in patients with acute myocardial infarction: a pilot study. J Lab Clin Med 1992;119:574-9.
10. Westlin WF, Gimbrone MA. Neutrophil-mediated damage of human vascular endothelium. Am J Pathol 1993;142: 117-28.
11. Gimbrone MA, Obin MS, Brock AF, Luis EA, Hass PE, Hébert CA, et al. Endothelial interleukin-8: a novel inhibitor of leukocyte-endothelial interactions. Science 1989;246: 1601-3.
12. Rot A. Endothelial cell binding of NAP-1/IL-8: role in neutrophil emigration. Immunol Today 1992;13:291-4.
13. Darbonne WC, Rice GC, Mohler MA, Hébert CA, Valente AJ, Baker JB. Red blood cells are a sink for interleukin 8, a leukocyte chemotaxin. J Clin Invest 1991;88:1362-9.
14. Baggiolini M, Dewald B, Moser B. Interleukin-8 and related chemotactic cytokines-CXC and CC chemokines. Adv Immunol 1995;55:97-161.
15. Huber AR, Kunkel SL, Todd RF, Weiss SJ. Regulation of transendothelial neutrophil migration by endogenous interleukin-8. Science 1991;254:99-102.
16. Kukielka GL, Wayne Smith C, LaRosa GJ, Manning AM, Mendoza LH, Daly TJ, et al. Interleukin-8 gene induction in the myocardium after ischemia and reperfusion in vivo. J Clin Invest 1994;95:89-103.
17. Johnson K, Aarden LA, Choi Y, De Groot E, Creasey A. The proinflammatory cytokine response to coagulation and endotoxin in whole blood. Blood 1996;12:5051-60.
18. Abe Y, Kawakami M, Kuroki M, Yamamoto T, Fujii M, Kobayashi H, et al. Transient rise in serum interleukin-8 concentration during acute myocardial infarction. Br Heart J 1993;70:132-4.
19. Siminiak T, Schroeder JM, Sticherling M, Wysocki H. Interleukin-8 is not involved in the increased chemotactic activity of peripheral blood plasma during acute myocardial infarction. Basic Res Cardiol 1993;88:150-4.
20. Tilg H, Shapiro L, Atkins MB, Dinarello CA, Mier JW. Induction of circulating and erythrocyte-bound IL-8 by IL-2 immunotherapy and suppression of its in vitro production by IL-1 receptor antagonist and soluble tumor necrosis factor receptor (p75) chimera. J Immunol 1993; 151:3299-307.
21. Neote K, Mak JY, Kolakowski LF, Schall TJ. Functional and biochemical analysis of the cloned Duffy antigen: identity with the red blood cell chemokine receptor. Blood 1994;84: 44-52.
22. Horuk R. The interleukin-8-receptor family: from chemokines to malaria. Immunol Today 1994;15:169-74.
23. Manten A, Pajkrt D, De Winter RJ, De Jong YP, Jansen J, Ten Cate JW, et al. Erythrocyte-bound IL-8 and RANTES in human endotoxemia. J Endocrinol Res 1997;4:1-7.
24. Tilg H, Pape D, Trehu E, Shapiro L, Atkins MB, Dinarello CA, et al. A method for the detection of erythrocyte-bound interleukin-8 in humans during interleukin-1 therapy. J Immunol Methods 1993;163:253-8.
25. Hohnloser SH, Zabel M, Kasper W, Meinertz T, Just H. Assessment of coronary artery patency after thrombolytic therapy: accurate prediction utilizing the combined analysis of three noninvasive markers. J Am Coll Cardiol 1991;18: 44-9.
26. Zabel M, Hohnloser SH, Koster W, Prinz M, Kasper W, Just H. Analysis of creatine kinase, CK-MB, myoglobin, and troponin T time - activity curves for early assessment of coronary artery reperfusion after intravenous thrombolysis. Circulation 1994;87:1542-50.
27. Kanda T, Hirao Y, Oshima S, Yuasa K, Taniguchi K, Nagai R, et al. Interleukin-8 as a sensitive marker of unstable coronary artery disease. Am J Cardiol 1996;77:304-7.
28. Neote K, Darbonne WC, Ogez J, Horuk R, Schall TJ. Identification of a promiscuous inflammatory peptide receptor on the surface of red blood cells. J Biol Chem 1993;286: 12247-9.
29. Furie MB, Randolph GJ. Chemokines and tissue injury. Am J Pathol 1995;146:1287-301.
30. Hadley TJ, Lu Z, Wasniowska K, Martin AW, Peiper SC, Hesselgesser J, et al. Postcapillary venule endothelial cells in kidney express a multispecific chemokine receptor that is structurally and functionally identical to the erythroid isoform, which is the Duffy blood group antigen. J Clin Invest 1994;94:985-91.
31. Peiper SC, Wang Z, Neote K, Martin AW, Showel HJ, Conklyn MJ, et al. The Duffy antigen/receptor for chemokines is expressed in endothelial cells of Duffy negative individuals who lack the erythrocyte receptor. J Exp Med 1995;181: 1311-17.
32. Grande P, Granborg J, Clemmensen P, Sevilla DC, Wagner NB, Wagner GS. Indices of reperfusion in patients with acute myocardial infarction using characteristics of the CK-MB time-activity curve. Am Heart J 1991;122:400-8.
33. Gorgels APM, Vos MA, Letsch IS, Verschuuren EA, Bar FW, Janssen JH, et al. Usefulness of the accelerated idioventricular rhythm as a marker for myocardial necrosis and reperfusion during thrombolytic therapy in acute myocardial infarction. Am J Cardiol 1988;61:231-5.
34. Clemmensen P, Ohman EM, Sevilla DC, Peck S, Wagner NB, Quigley PS, et al. Changes in standard electrocardiographic ST-segment elevation predictive of successful reperfusion in acute myocardial infarction. Am J Cardiol 1990;66:1407-11.
35. Pietilä K, Harmoinen A, Hermens W, Simoons ML, Van der Werf F, Verstraete M. Serum C-reactive protein and infarct size in myocardial infarct patients with a closed versus an open infarct-related coronary artery after thrombolytic therapy. Eur Heart J 1993;14:915-19.